INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2013

High-dose B vitamins slowed gray matter atrophy in elderly adults with elevated homocysteine.

In a randomized controlled trial of elderly adults with mild cognitive impairment over two years, daily high-dose B vitamins (0.8 mg folic acid, 20 mg B6, 0.5 mg B12) slowed whole-brain shrinkage and reduced gray matter atrophy in Alzheimer-vulnerable regions up to sevenfold. This protective effect was restricted to participants with baseline homocysteine levels above 11 micromol/L. In that subgroup, B-vitamin therapy countered the rapid gray matter loss linked to elevated homocysteine.

Study type
Randomized controlled trial
Who was studied
Elderly adults with mild cognitive impairment
What was measured
Gray matter and whole brain volume atrophy

THE PAPER

Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment.

Douaud G, Refsum H, de Jager CA, Jacoby R, Nichols TE, Smith SM, Smith AD. Proc Natl Acad Sci U S A, 2013.

PubMed 23690582 ↗DOI 10.1073/pnas.1301816110 ↗

Nutrients & adequacyBrain & moodHealthy aging & longevity

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.